Novel Supplement-based Therapy for the Treatment of Small Intestinal Bacterial Overgrowth

NCT03420976 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped PI no longer in practice.

Conditions

Small Intestinal Bacterial Overgrowth

Interventions

DIETARY_SUPPLEMENT: Novel Supplement Based Therapy

Sponsor

Atrium Innovations

Collaborators

[object Object]
[object Object]